{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:18:04Z","timestamp":1787062684627,"version":"build-2736575974"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.jpba.2022.114728","type":"journal-article","created":{"date-parts":[[2022,3,16]],"date-time":"2022-03-16T03:07:50Z","timestamp":1647400070000},"page":"114728","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["3,4-Methylenedioxymethamphetamine quantification via benchtop 1H qNMR spectroscopy: Method validation and its application to ecstasy tablets collected at music festivals"],"prefix":"10.1016","volume":"214","author":[{"given":"Anca","family":"Frinculescu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander F.G.","family":"Maier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trevor","family":"Shine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Ramsey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan F.","family":"Araneda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne D.","family":"Riegel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nunzianda","family":"Frascione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Abbate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2022.114728_bib1","unstructured":"Public Health England, Health matters: preventing drug misuse deaths. \u3008https:\/\/www.gov.uk\/government\/publications\/health-matters-preventing-drug-misuse-deaths\/health-matters-preventing-drug-misuse-deaths\u3009, 2017 (accessed 22 August 2021)."},{"key":"10.1016\/j.jpba.2022.114728_bib2","unstructured":"Office for National Statistics, Deaths related to drug poisoning in England and Wales: 2020 registrations. \u3008https:\/\/www.ons.gov.uk\/peoplepopulationandcommunity\/birthsdeathsandmarriages\/deaths\/bulletins\/deathsrelatedtodrugpoisoninginenglandandwales\/2020\u3009, 2021 (accessed 22 August 2021)."},{"issue":"4","key":"10.1016\/j.jpba.2022.114728_bib3","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1093\/anatox\/35.4.219","article-title":"Deaths involving MDMA and the concomitant use of pharmaceutical drugs","volume":"35","author":"Pilgrim","year":"2011","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.jpba.2022.114728_bib4","unstructured":"Home Office, United Kingdom drug situation 2019: summary. \u3008https:\/\/www.gov.uk\/government\/publications\/united-kingdom-drug-situation-focal-point-annual-report\/uk-drug-situation-2019-summary\u3009, 2019 (accessed 19 September 2021)."},{"key":"10.1016\/j.jpba.2022.114728_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.108315","article-title":"What is the drug of choice of young festivalgoers?","volume":"216","author":"Bade","year":"2020","journal-title":"Drug Alcohol Depend."},{"issue":"8","key":"10.1016\/j.jpba.2022.114728_bib6","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1002\/dta.2605","article-title":"Variability in content and dissolution profiles of MDMA tablets collected in the UK between 2001 and 2018 - A potential risk to users?","volume":"11","author":"Couchman","year":"2019","journal-title":"Drug Test. Anal."},{"issue":"6","key":"10.1016\/j.jpba.2022.114728_bib7","doi-asserted-by":"crossref","first-page":"3845","DOI":"10.1021\/acs.analchem.8b04168","article-title":"Rapid on-site detection of illegal drugs in complex matrix by thermal eesorption acetone-assisted photoionization miniature ion trap mass spectrometer","volume":"91","author":"Wang","year":"2019","journal-title":"Anal. Chem."},{"issue":"4","key":"10.1016\/j.jpba.2022.114728_bib8","doi-asserted-by":"crossref","first-page":"7103","DOI":"10.1021\/acsomega.9b00302","article-title":"Rapid identification of novel psychoactive and other controlled substances using low-field (1)H NMR spectroscopy","volume":"4","author":"Antonides","year":"2019","journal-title":"ACS Omega"},{"key":"10.1016\/j.jpba.2022.114728_bib9","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/3104569","article-title":"The application of a desktop NMR spectrometer in drug analysis","volume":"2018","author":"Zhong","year":"2018","journal-title":"Int J. Anal. Chem."},{"key":"10.1016\/j.jpba.2022.114728_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.forc.2020.100263","article-title":"Quantification of MDMA in seized tablets using benchtop 1H NMR spectroscopy in the absence of internal standards","volume":"20","author":"Hussain","year":"2020","journal-title":"Forensic Chem."},{"issue":"40","key":"10.1016\/j.jpba.2022.114728_bib11","doi-asserted-by":"crossref","first-page":"4853","DOI":"10.1039\/D0AY01511C","article-title":"Quantitative analysis of cannabinoids using benchtop NMR instruments","volume":"12","author":"Araneda","year":"2020","journal-title":"Anal. Methods"},{"key":"10.1016\/j.jpba.2022.114728_bib12","first-page":"1","article-title":"Identification of seven psychedelic 2,5-dimethoxy-phenylethyl-amine-based designer drugs via benchtop 1H nuclear magnetic resonance spectroscopy","author":"Araneda","year":"2021","journal-title":"Magn. Reson Chem."},{"issue":"1","key":"10.1016\/j.jpba.2022.114728_bib13","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/pca.2921","article-title":"Low-field benchtop NMR spectroscopy: status and prospects in natural product analysis(\u2020)","volume":"32","author":"van Beek","year":"2021","journal-title":"Phytochem Anal."},{"key":"10.1016\/j.jpba.2022.114728_bib14","unstructured":"T. Schoenberger, Guideline for qNMR analysis. \u3008https:\/\/enfsi.eu\/wp-content\/uploads\/2017\/06\/qNMR-Guideline_version001.pdf\u3009, 2019 (accessed 24 January 2022)."},{"key":"10.1016\/j.jpba.2022.114728_bib15","unstructured":"M.A. Bernstein, I\u2019m new to qNMR: where can I get basic guidance on how to do it?. \u3008https:\/\/amberanalytical.com\/qnmr\/qnmr-intro\/\u3009, 2022 (accessed 24 January 2022)."},{"key":"10.1016\/j.jpba.2022.114728_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2019.112847","article-title":"Quo vadis qNMR?","volume":"177","author":"Diehl","year":"2020","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"9","key":"10.1016\/j.jpba.2022.114728_bib17","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1111\/j.1360-0443.2006.01511.x","article-title":"The origin of MDMA (ecstasy) revisited: the true story reconstructed from the original documents","volume":"101","author":"Freudenmann","year":"2006","journal-title":"Addiction"},{"key":"10.1016\/j.jpba.2022.114728_bib18","unstructured":"European Monitoring Centre for Drugs and Drug Addiction, Recent changes in Europe's MDMA\/ecstasy market: results from an EMCDDA trendspotter study, European Monitoring Centre for Drugs and Drug Addiction. \u3008https:\/\/www.emcdda.europa.eu\/system\/files\/publications\/2473\/TD0116348ENN.pdf\u3009, 2016 (accessed 04 September 2021)."},{"issue":"2","key":"10.1016\/j.jpba.2022.114728_bib19","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1002\/dta.1954","article-title":"Drug testing in europe: monitoring results of the trans european drug information (TEDI) project","volume":"9","author":"Brunt","year":"2017","journal-title":"Drug Test. Anal."},{"issue":"1","key":"10.1016\/j.jpba.2022.114728_bib20","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s12954-017-0179-5","article-title":"An overview of forensic drug testing methods and their suitability for harm reduction point-of-care services","volume":"14","author":"Harper","year":"2017","journal-title":"Harm Reduct. J."},{"key":"10.1016\/j.jpba.2022.114728_bib21","unstructured":"Chicago-Kent College of Law, Preventing drug-related deaths at music festivals: Why the \"Rave\" Act should be amended to provide an exception for harm reduction services. \u3008https:\/\/scholarship.kentlaw.iit.edu\/cklawreview\/vol93\/iss3\/12\u3009, 2018 (accessed 24 October 2021)."},{"key":"10.1016\/j.jpba.2022.114728_bib22","unstructured":"United Nations Office on Drugs and Crime, Validation of analytical methodology and calibration of equipment used for testing of illicit drugs in seized materials and biological specimens. \u3008https:\/\/www.unodc.org\/documents\/scientific\/validation_E.pdf\u3009, 2009 (accessed 04 September 2021)."},{"issue":"11","key":"10.1016\/j.jpba.2022.114728_bib23","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1002\/mrc.4004","article-title":"A comparison of quantitative nuclear magnetic resonance methods: internal, external, and electronic referencing","volume":"51","author":"Cullen","year":"2013","journal-title":"Magn. Reson Chem."},{"issue":"9","key":"10.1016\/j.jpba.2022.114728_bib24","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.3390\/molecules22091517","article-title":"The application of quantitative 1H NMR for the determination of orlistat in tablets","volume":"22","author":"Sun","year":"2017","journal-title":"Molecules"},{"issue":"23","key":"10.1016\/j.jpba.2022.114728_bib25","doi-asserted-by":"crossref","first-page":"4921","DOI":"10.1021\/ac980573i","article-title":"Method performance and validation for quantitative analysis by (1)h and (31)p NMR spectroscopy. Applications to analytical standards and agricultural chemicals","volume":"70","author":"Maniara","year":"1998","journal-title":"Anal. Chem."},{"issue":"6","key":"10.1016\/j.jpba.2022.114728_bib26","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1093\/jat\/20.6.432","article-title":"Analysis of 3,4-methylenedioxymethamphetamine (MDMA) and its metabolites in plasma and urine by HPLC-DAD and GC-MS","volume":"20","author":"Helmlin","year":"1996","journal-title":"J. Anal. Toxicol."},{"issue":"3","key":"10.1016\/j.jpba.2022.114728_bib27","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1136\/emj.16.3.194","article-title":"Analysis of illicit ecstasy tablets: implications for clinical management in the accident and emergency department","volume":"16","author":"Sherlock","year":"1999","journal-title":"J. Accid. Emerg. Med."},{"key":"10.1016\/j.jpba.2022.114728_bib28","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.forsciint.2016.04.016","article-title":"Crystals and tablets in the Spanish ecstasy market 2000-2014: are they the same or different in terms of purity and adulteration?","volume":"263","author":"Vidal Gin\u00e9","year":"2016","journal-title":"Forensic Sci. Int."},{"issue":"3","key":"10.1016\/j.jpba.2022.114728_bib29","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1111\/1556-4029.13968","article-title":"Detection of cutting agents in drug-positive seized exhibits within the United States","volume":"64","author":"Fiorentin","year":"2019","journal-title":"J. Forensic Sci."},{"issue":"1","key":"10.1016\/j.jpba.2022.114728_bib30","first-page":"221","article-title":"Impact of pharmaceutical impurities in ecstasy tablets: gas chromatography-mass spectrometry study","volume":"15","author":"Jalali","year":"2016","journal-title":"Iran. J. Pharm. Res."},{"issue":"1","key":"10.1016\/j.jpba.2022.114728_bib31","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1080\/02791072.2009.10400672","article-title":"What\u2019s in a label? Ecstasy sellers\u2019 perceptions of pill brands","volume":"41","author":"Duterte","year":"2009","journal-title":"J. Psychoact. Drugs"},{"issue":"3\u20134","key":"10.1016\/j.jpba.2022.114728_bib32","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1007\/s00213-003-1712-7","article-title":"Is ecstasy MDMA? A review of the proportion of ecstasy tablets containing MDMA, their dosage levels, and the changing perceptions of purity","volume":"173","author":"Parrott","year":"2004","journal-title":"Psychopharmacol."},{"issue":"9","key":"10.1016\/j.jpba.2022.114728_bib33","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1136\/emj.2010.092270","article-title":"Variability in the 3,4-methylenedioxymethamphetamine content of \u2018ecstasy\u2019 tablets in the UK","volume":"28","author":"Wood","year":"2011","journal-title":"Emerg. Med. J."},{"key":"10.1016\/j.jpba.2022.114728_bib34","first-page":"15620","article-title":"Changes in illicit drug use and markets with the COVID-19 pandemic and associated restrictions: findings from the ecstasy and related drugs reporting system, 2016-20","author":"Price","year":"2021","journal-title":"Addiction"},{"issue":"9","key":"10.1016\/j.jpba.2022.114728_bib35","doi-asserted-by":"crossref","first-page":"4789","DOI":"10.3390\/ijerph18094789","article-title":"Illicit drug use and associated problems in the nightlife scene: a potential setting for prevention","volume":"18","author":"Feltmann","year":"2021","journal-title":"Int. J. Environ. Res. Public Health"}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708522001492?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708522001492?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T09:21:08Z","timestamp":1760001668000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708522001492"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":35,"alternative-id":["S0731708522001492"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2022.114728","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"3,4-Methylenedioxymethamphetamine quantification via benchtop 1H qNMR spectroscopy: Method validation and its application to ecstasy tablets collected at music festivals","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2022.114728","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"114728"}}